Ostarine is SARM, which has been developed to prevent and treat the loss of muscle mass.
It is currently in clinical trials and can finally be used to prevent cachexia, atrophy and sarcopenia through the use of a prescription, even for the treatment of male hormones and testosterone.
In chemical research, Ostarine belongs to a group of chemicals known as SARM or selective modulators of the androgen receptor. SARM generates selective anabolic activity in certain androgen receptors, and not in others that cause unwanted effects, hence its name. Compared with testosterone and other anabolic steroids and advantages of SARM pro-hormones, such as (Ostarine) MK2866 it has no androgenic activity of non-skeletal muscle tissue.
Ostarine can not only maintain lean body mass (LBM), but can actually increase it.
S1 is often described or named in different Internet sources, although this is really incorrect, since S1 was a very early SARM, which we could call it, but now it has its name and specific chemical composition that should not be further developed.
How does it work?
Selective androgen receptor modulators (SARM) bind to the junction of “OSTEO” (bone) and “MYO” (muscle) that binds to the androgen receptor in anabolic activity to activate the androgen receptor.
The binding and activation of the androgen receptor will alter the expression of genes, increase the synthesis of proteomes and, therefore, exert muscle relaxation. Therefore, essentially, SARM, such as ostarine, causes muscle growth in the same way as steroids, but does not produce the effects of growth of the prostate and other secondary sex organs such as non-steroidal drugs.
Especially ostarine, practically exerts anabolic effects on muscle tissue. Therefore, not only is it a potential new treatment for a broad spectrum of muscle diseases (such as AIDS or cancer), but bodybuilders, fitness, athletes and agents also have great potential for muscle construction to minimize atrophy of surgery or other similar situations.